GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OBI Pharma Inc (ROCO:4174) » Definitions » Market Cap

OBI Pharma (ROCO:4174) Market Cap : NT$16,689.28 Mil (As of Sep. 25, 2024)


View and export this data going back to 2015. Start your Free Trial

What is OBI Pharma Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). OBI Pharma's share price for the quarter that ended in Jun. 2024 was NT$60.8. OBI Pharma's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 229.25 Mil. Therefore, OBI Pharma's market cap for the quarter that ended in Jun. 2024 was NT$13,938.28 Mil.

OBI Pharma's quarterly market cap declined from Dec. 2023 (NT$15,909.81 Mil) to Mar. 2024 (NT$14,305.08 Mil) and declined from Mar. 2024 (NT$14,305.08 Mil) to Jun. 2024 (NT$13,938.28 Mil).

OBI Pharma's annual market cap declined from Dec. 2021 (NT$22,680.06 Mil) to Dec. 2022 (NT$15,808.49 Mil) but then increased from Dec. 2022 (NT$15,808.49 Mil) to Dec. 2023 (NT$15,909.81 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. OBI Pharma's Enterprise Value for Today is NT$15,352.09 Mil.


OBI Pharma Market Cap Historical Data

The historical data trend for OBI Pharma's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OBI Pharma Market Cap Chart

OBI Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24,833.00 27,646.00 22,680.06 15,808.49 15,909.81

OBI Pharma Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22,248.50 18,683.71 15,909.81 14,305.08 13,938.28

Competitive Comparison of OBI Pharma's Market Cap

For the Biotechnology subindustry, OBI Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OBI Pharma's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OBI Pharma's Market Cap distribution charts can be found below:

* The bar in red indicates where OBI Pharma's Market Cap falls into.



OBI Pharma Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

OBI Pharma's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=NT$69.4*229.248
=NT$15,909.81

OBI Pharma's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )=Share Price (Q: Jun. 2024 )*Shares Outstanding (EOP) (Q: Jun. 2024 )
=NT$60.8*229.248
=NT$13,938.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OBI Pharma  (ROCO:4174) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


OBI Pharma Market Cap Related Terms

Thank you for viewing the detailed overview of OBI Pharma's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


OBI Pharma Business Description

Traded in Other Exchanges
N/A
Address
No. 3, Park Street, Room. 1907, 19th Floor, Nangang District, Taipei, TWN, 115
OBI Pharma Inc is part of the healthcare sector. The company and its subsidiaries are engaged in new drug research. Its focus is on the unmet medical need in challenging diseases throughout the world, such as cancer. OBI strives to improve health and the quality of life through cost-effective therapeutics. The Group has four reportable segments, which are the anti-cancer new drug segment, bispecific monoclonal antibody new drug segment, botulinum toxin new drug segment, and CDMO segment.

OBI Pharma Headlines

No Headlines